Skip to Content

Tag: Option Care


John Rademacher

Specialty Providers

Option Care pushes through disaster for strong quarter

November 1, 2024Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – Despite disruption to its supply chain, Option Care Health’s quick and “aggressive” response allowed the provider to continue servicing patients, with minimal impact, CEO John Rademacher said.  In the aftermath of Hurricane Helene, flooding halted production of intravenous solution bags at the Baxter International plant in Marion, N.C.  “From the moment of the closure, needless to say, there were immediate actions that we took to not...

Home Infusion Therapy, Hurricane Helene, IV shortage, John Rademacher, Option Care


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care details impact of cyberattack

April 26, 2024Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – Option Care Health’s cash flow during the first quarter was negatively impacted by the Change Healthcare cyberattack, but the company has not changed its outlook for the full year, executives said on a recent earnings call.  From the date of the cyberattack on February 21 through the rest of the quarter, Option Care was unable to submit more than half its claims, said John Rademacher, president and CEO.   “This has resulted in a detrimental...

Cyberattack, Home Infusion, Option Care


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care reports double-digit growth 

April 23, 2024HME News Staff

BANNOCKBURN, Ill. – Option Care Health reported revenue of $1.14 billion for the first quarter of 2024, an increase of 12.8% compared to the same quarter last year, despite the disruption caused by the Change Healthcare cyberattack in February.  “The Option Care Health team delivered solid financial results while navigating a disruptive environment,” said John Rademacher, CEO. “I am proud of the resilient enterprise we have built and the team's unwavering commitment...

Change Healthcare, Cyberattack, Financial Results, Option Care


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care monitors ‘vigorous’ competition

March 1, 2024Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – The trend of payers integrating with providers, including Elevance Health’s recent acquisition of Paragon Healthcare, a Texas-based infusion provider, is a shift that Option Care Health is keeping a close eye on, says CEO John Rademacher.  “They're vigorous competitors and so we take that full view as we're approaching the marketplace,” he said on a recent call to discuss the company’s fourth quarter and full year earnings. “Our...

Home Infusion Therapy, John Rademacher, Option Care


Read Full Articlered right arrow icon

News

In brief: Change Healthcare breach, Option Care results, Masimo collaboration

February 23, 2024HME News Staff

MINNEAPOLIS, Minn. – Change Healthcare, a revenue cycle management company, has experienced a cyberattack, it stated on its website.  “Once we became aware of the outside threat, in the interest of protecting our partners and patients, we took immediate action to disconnect our systems to prevent further impact. At this time, we believe the issue is specific to Change Healthcare and all other systems across UnitedHealth Group are operational.”  UnitedHealth Group...

AAHomecare, Change Healthcare, Masimo, Option Care, United Spinal Association


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care delivers ‘strong results’

February 22, 2024HME News Staff

BANNOCKBURN, Ill. – Option Care Health reported revenue of $1.12 billion for the fourth quarter of 2023, an increase of 9.5% compared to the same quarter in 2022.  Revenue for the full year was $4.3 billion, up 9.1% compared to 2022. Gross profit for the quarter was $247.1 million and adjusted EBITDA was $111.6 million.  “The Option Care Health team delivered strong financial results in the fourth quarter and full year of 2023 and continued to execute on our commitment...

Home Infusion, John Rademacher, Option Care


Read Full Articlered right arrow icon

Also Noted

Option Care plans to complete stock repurchase in Q4

December 7, 2023HME News Staff

BANNOCKBURN, Ill. – Option Care Health plans to complete the remaining $75 million of repurchases in the fourth quarter under an original authorization. In addition, the company’s board of directors approved an increase to its share repurchase program authorization from $250 million to $500 million. The program has no specified expiration date. During a call in October to discuss its third quarter earnings, Option Care said it had completed a repurchase of approximately $100 million in...

Home Infusion Therapy, Option Care


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care still bullish on buying

October 27, 2023Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – Option Care Health still sees plenty of opportunity to grow through acquisitions, but it plans to stick closer to its core business of home infusion, said company execs on a recent earnings call.  It’s a sign the company has moved on from its terminated $3.6 billion merger in June with Amedysis, a provider of home health, hospice and high-acuity care.   “We really thought that Amedisys was unique in its capability set, certainly with its...

Home Infusion, John Rademacher, Option Care


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care ‘builds momentum’ in Q3

October 25, 2023HME News Staff

BANNOCKBURN, Ill. – Option Care reported net revenue of $1.09 billion for the third quarter of 2023, an increase of 7.1% year over year, and net income of $56.3 million, an increase of 45%.  Gross profit was $254.3 million, up 16.6%, and adjusted EBITDA was $109.8 million, up 28.2%.  “The Option Care Health team continues to execute on outstanding clinical outcomes and extraordinary patient care, which helped translate into solid financial results in the third quarter,”...

Home Infusion Therapy, John Rademacher, Option Care


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care leans on ‘momentum of base business’ in wake of failed deal

July 28, 2023Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – Option Care will return nearly all of a $106 million break-up fee to shareholders, as the company moves on from its failed merger with Amedisys, said CEO John Rademacher.  Option Care announced in June that it had terminated its $3.6 billion merger with Amedisys, just weeks after the two companies announced the deal.  “Given the strength of our balance sheet and forward outlook, we believe it is appropriate to return essentially all of the break fee...

Home Infusion, John Rademacher, Option Care


Read Full Articlered right arrow icon